The Food and Drug Administration’s approval of the abortion drug RU-486 sparked a new round of debate between pro-life and pro-choice activists, but it also brought forth a new discussion about the drug’s medical benefits and drawbacks, who will be allowed to administer it, and how states will regulate its use. A panel talks about the new concerns raised by the introduction of RU-486 in the U.S.


  • Richard Pierce professor of administrative law at George Washington University
  • Dr. Mitchell Creinin physician
  • Maxine Klane Planned Parenthood of Metropolitan Washington

Related Links

Topics + Tags


comments powered by Disqus
Most Recent Shows

A Conversation With “Broad City” Co-Star Abbi Jacobson

Wednesday, Oct 26 2016What do Michelle Obama, Anna Wintour and Michael Jordan carry in their bags? Abbi Jacobson imagines the things you might find in her new illustrated book, "Carry This Book." We talk to the "Broad City" co-star about what you can learn from the contents of bags—and her success creating and starring in the hit Comedy Central show.

AT&T’s Proposed Acquisition Of Time Warner

Tuesday, Oct 25 2016AT&T’s bid to acquire Time Warner: Join us to talk about what the proposed merger of the country’s second-largest wireless carrier and a major content company could mean for consumers and the future of U.S. media and telecommunications.